MEDIPOST Co., Ltd. (KOSDAQ:078160)
South Korea flag South Korea · Delayed Price · Currency is KRW
13,990
-1,200 (-7.90%)
May 20, 2026, 3:30 PM KST

MEDIPOST Company Description

Medipost Co., Ltd. engages in the development and manufacture of stem cell biotechnology products.

It operates through the following business divisions: Cord Blood Bank, Stem Cell Therapy, Health Functional Food, Import and Distribution of Natural Cosmetics and Healthcare Services.

The Cord Blood Bank division is involved in collecting and storing stem cells from the newborn's umbilical cord.

The Stem Cell Therapy division manufactures allogeneic stem cell drug products. The Health Functional Food division offers vitamins and nutritional supplements.

The Import and Distribution of Natural Cosmetics division is involved in the sales and marketing of natural cosmetics imported by Pevonia Inc. The Healthcare Services division provides healthcare solutions such as bizcare, insu-care, affiliate, telehealth services and medical devices through web, mobile, and call centers.

The company was founded by Yoon-Sun Yang and Won-Il Oh on June 26, 2000 and is headquartered in Seongnam, South Korea.

MEDIPOST Co., Ltd.
CountrySouth Korea
Founded2000
IndustryBiotechnology
SectorHealthcare
CEOWon-il Oh

Contact Details

Address:
21, Daewangpangyo-ro
Seongnam-si
South Korea
Phone82 2 3465 6677

Stock Details

Ticker Symbol078160
ExchangeKOSDAQ
Fiscal YearJanuary - December
Reporting CurrencyKRW
ISIN NumberKR7078160009
SIC Code2836

Key Executives

NamePosition
Won-il OhChief Executive Officer